Molson Coors Beverage (TAP) Earnings Analysis
Molson Coors Beverage (TAP) next reports earnings on 2026-08-06, consensus EPS 1.52 USD. Last quarter (2026-04-30) it beat with EPS 0.62 USD vs 0.36 USD est (+72.2%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E -3.86.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TAP next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 1.52 USD |
| Revenue estimate | 3.08B |
TAP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 0.62 USD | 0.36 USD | +72.2% | Beat |
| 2026-02-18 | 1.21 USD | 1.17 USD | +3.4% | Beat |
| 2025-05-08 | 0.5 USD | 0.783 USD | -36.1% | Miss |
| 2025-02-13 | 1.3 USD | 1.17 USD | +11.1% | Beat |
| 2024-11-07 | 1.8 USD | 1.67 USD | +7.8% | Beat |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
TAP valuation and analyst view
| Trailing P/E | -3.86 |
|---|---|
| Trailing EPS | -11.16623 USD |
| Price / book | 0.77 |
| Dividend yield | 4.63% |
| Market cap | 7.68B |
| Analyst consensus | Hold (11 buy / 20 hold / 6 sell) |
| Avg price target | 41.83 USD |
Related research pages
Frequently asked questions
When is Molson Coors Beverage (TAP)'s next earnings date?
Molson Coors Beverage is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 1.52 USD and revenue estimate of 3.08B.
Did TAP beat earnings last quarter?
In its 2026-04-30 report, TAP posted EPS of 0.62 USD versus a 0.36 USD estimate — a beat of 72.2%.
What is TAP's earnings track record?
Over the last 5 reported quarters with consensus data, TAP beat estimates 4 times (80%).
What is TAP's current P/E ratio and EPS?
TAP trades at a trailing P/E of -3.86 on trailing EPS of -11.16622551614611 USD.
What do analysts rate TAP?
Analyst consensus is "Hold" across 37 ratings (0 strong buy, 11 buy, 20 hold, 6 sell, 0 strong sell). Average 12-month price target: 41.83 USD.